|
Harvard Bioscience Incorporated, founded as Harvard Apparatus Incorporated in 1996, develops scientific instruments that optimize pharmaceutical and biotechnology drug discovery operations. The firm was established with the acquisition of assets from Harvard Apparatus, which was founded in 1901. In 2000, the firm was reincorporated under its current name. Harvard Bioscience is known for its Harvard Apparatus, Genomic Solutions, Cartesian Technologies, Biochrom, GeneMachines, Hoefer, and Union Biometrica product lines. The systems streamline target validation, assay development, and ADMET screening processes. The company offers customers microplate readers, washers, low-volume liquid dispensers, electroporation and electrofusion molecular delivery products, conductivity meters, colorimeters, spectrophotometers, and other systems. The firm markets systems directly to thousands of researchers across 100 countries. It also works with distributors, including GE Healthcare and Fisher Scientific. Harvard Bioscience is based in Holliston, Massachusetts. It has 21 wholly owned subsidiaries. The firm maintains offices in the United States, the United Kingdom, German, Austria, and Belgium. It has sales offices in France and Canada. Harvard Bioscience went public in 2000. The company is listed on NASDAQ under the HBIO symbol.
|